Schedule 13G ownership disclosure
CATABASIS PHARMACEUTICALS IN
Security class unavailable · CUSIP: 14875P107
Event date: 2015-06-25
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 6.3800%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001546927-15-000191
- Form type
- SC 13G
- Filer
- Astria Therapeutics, Inc.
- CIK
- CIK 1454789
- Filed
- Jul 06, 2015
- Reporting period
- Jun 25, 2015
- Description
- Schedule 13G beneficial ownership